Date: Thursday, April 11, 2024
Time: 7:00 PM Central Time (US & Canada)
Moderators: Paula Denoya, MD, FACS, FASCRS
Speakers: Stefan Holubar MD, MS, FACS, FASCRS; Emily Steinhagen MD, FACS, FASCRS; Bo Shen, MD
CME Credit Hours Available: 1 AMA PRA Category 1 Credit(s)™
With increased use of biologic therapies for Crohn’s disease, the surgical therapy is also evolving. This webinar will explore perioperative optimization, surgical approaches and innovative interventional endoscopic interventions as well.
At the conclusion of this session, participants should be able to:
- Learn about nutritional optimization before surgery, perioperative management of biologic and steroid therapy to improve patient outcomes.
- Understand the indications for surgery and when to offer different surgical approaches.
- Learn about different endoscopic options for Crohn’s complications and when to recommend this approach.
Moderator
Paula Denoya, MD, FACS, FASCRS
Dr. Denoya received her BA from New York University and MD from Mount Sinai School of Medicine, where she also completed a residency in general surgery. She then went on to complete a residency in colorectal surgery at Cleveland Clinic Florida. Dr. Denoya has been a member of the department of surgery at Stony Brook University Hospital since 2009, where she is Associate Professor of Surgery and the Program Director for the Colorectal Surgery Residency Program.
Speakers
Stefan Holubar MD, MS, FACS, FASCRS
Dr. Holubar received his MD from University of Vermont. He completed a General Surgery Residency at North Shore-LIJ, and then a 2-year Master’s in Clinical and Translational Research, and a clinical Colorectal Fellowship at Mayo Clinic Rochester. After Mayo, he joined Dartmouth-Hitchcock Medical Center and was appointed Chief of the Division of Colon and Rectal Surgery in 2015. In April 2017, Dr. Holubar was appointed Vice-President of the American Society of Enhanced Recovery. In August 2017, Dr. Holubar accepted a position as a Staff Surgeon at Cleveland Clinic Ohio, where he presently serves as the IBD Surgery Section Chief and the Director of Research in the Department of Colon and Rectal Surgery, and as the NSQIP Surgeon Champion for the Cleveland Clinic Foundation.
On a national level, Dr. Holubar is actively engaged in helping lead the NSQIP IBD Collaborative and serves as Chair for the ASCRS IBD Committee. To date he has published over 220 peer-reviewed articles, more than half of which are on IBD, a dozen book chapters, and 1 book (coeditor). His main clinical and research focus is IBD, with a special interest in Med-Surg pouch (IPAA) topics/issues, complex Crohn’s and Colitis, and venous thromboembolism prophylaxis in IBD. He has received several research grants including from the Crohn’s & Colitis Foundation and the ASCRS to study VTE prophylaxis after surgery for IBD and the role of pyridostigmine in post-operative ileus. Recent contributions to the field of IBD surgery include describing Twisted Pouch Syndrome, and the Mesenteric Excision and Exclusion procedure. Finally, Dr. Holubar is the PI for the newly funded Crohn’s & Colitis Foundation’s surgical cohort and collaborative, IBD-SIRQC (IBD Surgical Innovation, Research, and Quality Collaborative).
Emily Steinhagen MD, FACS, FASCRS
Dr. Steinhagen is an Associate Professor of Surgery at Case Western Reserve University School of Medicine. She is a graduate of Williams College and the Icahn School of Medicine at Mount Sinai. She completed her general surgery training at The Mount Sinai Medical Center and residency in colon and rectal surgery at the University of Chicago. Dr. Steinhagen has a diverse practice that includes most aspects of colon and rectal surgery including colon and rectal cancer, ulcerative colitis, Crohn’s disease, anorectal disease, and other pathologies. In addition, she has an interest and several leadership roles in surgical education. She is an author of numerous book chapters, and her manuscripts have been published in peer-reviewed medical journals.
Bo Shen, MD
Dr. Shen is a clinician, physician-scientist, educator, and author. He is the Edelman-Jarislowsky Professor of Surgical Sciences, Professor of Medicine and Surgical Sciences (in Surgery), Vice-Chair for Innovation of Departments of Medicine and Surgery, Director of Interventional IBD Center, and Medical Director of IBD Center at the Columbia University Irving Medical Center/NewYork- Presbyterian Hospital, New York, NY. Before he joined Columbia University in 2019, he had had a long tenure as the Ed and Joey Story Endowed Chair, Professor of Medicine of Lerner College of Medicine of Case Western Reserve University, Section Head of IBD, Department of Gastroenterology/Hepatology, Cleveland Clinic, Cleveland, OH. Dr. Shen specializes in the medical and endoscopic management of inflammatory bowel disease (IBD), colorectal surgery-associated complications, pouchitis, and ileal pouch disorders. He established the subspecialty Pouchitis Clinic at the Cleveland Clinic in 2002, the first and the largest of its kind in the world. He is also credited for the establishment of the first endoscopy unit specializing in the treatment of IBD and colorectal surgery complications (the Cleveland Clinic Interventional IBD [i-IBD] Unit) in the world. He also established the first Interventional IBD Fellowship in the US for the training of PGY7 GI fellows. He is the founder of the Global Interventional IBD Group and founding chair of the American Society for Gastrointestinal Endoscopy’s (ASGE) Special Interest Group of Interventional IBD. Dr. Shen has conducted numerous clinical and translational research projects in IBD, endoscopy, and pouch disorders and his research has been funded by the National Institutes of Health (NIH), American Gastroenterological Association (AGA), American College of Gastroenterology (ACG), Broad Foundation, Crohn’s and Colitis Foundation (CCF), American Society of Colorectal Surgeons, and philanthropic funds. He lectures extensively in the US and abroad. He has published 590 peer-reviewed articles in high-impact journals, including NEJM, Science, Nat Immunol, Nat Rev Gastroenterol Hepatol, PNAS, Gastroenterology, Lancet Gastroenterol Hepatol, and Gut. He led the development of a series of consensus guidelines in the endoscopic management of IBD complications and ileal pouch disorders (Lancet Gastroenterol Hepatol). He is a contributor to UpToDate®. He edited 5 reference books and co-edited 4 textbooks/reference books on IBD, pouch disorders, and interventional IBD. He published more than 500 meeting abstracts and 40 book chapters. He has been a visiting professor/guest professor in 50 leading academic institutions in Australia, Belgium, Brazil, Canada, China, Czech Republic, India, Ireland, Israel, Japan, Korea, Spain, Serbia, Turkey, the Philippines, and the US. Dr. Shen is a grant reviewer for the NIH, ACG, CCF, and Broad Foundation. Dr. Shen has served on editorial boards in major professional journals and has also served on the advisory board for the Food and Drug Administration. Dr. Shen holds a Fellowship in AGA, ACG, and ASGE. He has committee assignments from Columbia University, AGA, ACG, ASGE, and the Cleveland Clinic. Dr. Shen has won numerous awards, including the 2023 AGA Distinguished Clinician Award in Academic Practice, Professor Emeritus Florida Digestive Disease Update, the Ed and Joey Story Endowed Chair, the Edelman-Jarislowsky Professor of Surgical Sciences, the Physician of the Year Award and Senior Fellow Teacher of the Year Award from Department of Gastroenterology/Hepatology, the Cleveland Clinic, Physician/Physician Assistant Team of Year Award of the Cleveland Clinic Foundation, and the Premier Physician of Year Award from CCF Northeast Ohio Chapter. He has been the primary research mentor for more than 100 medical students, residents, GI and colorectal surgery fellows, IBD fellows, junior faculty, and overseas scholars.
Accreditation Statement
The American Society of Colon and Rectal Surgeons (ASCRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Designation Statement
ASCRS designates this live activity for a maximum of 1 AMA PRA Category 1 Credits(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Surgery (ABS) Continuous Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Disclosures and Conflict of Interest
Every person who is involved as committee members, educational planners, presenters, moderators, reviewers, and other individuals in a position to control or influence the content of an activity has disclosed. All disclosed relationships have been reviewed and managed. There are no relevant financial relationships to disclose.
REGISTER HERE
Registration Fees: ASCRS Members FREE; Non-Members $50